Dimitra Sakellari

Prof. Dimitra Sakellari

Department of Preventive Dentistry, Periodontology and Implant Biology Dental School, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
TSTimo Sorsa
Timo Sorsa
SSaeed Alassiri
Saeed Alassiri
AGAndreas Grigoriadis
Andreas Grigoriadis
IRIsmo T. Räisänen
Ismo T. Räisänen
PPPirjo Parnanen
Pirjo Parnanen
DSDimitra Sakellari
Dimitra Sakellari
The aim of this study was to investigate the utility of incorporating active matrix metalloproteinase-8 (aMMP-8) as a biomarker into the new periodontitis classification system (stage/grade) presented in 2018. This study included 150 Greek adults aged 25–78, of whom 74 were men and 76 women. Participants were tested with an aMMP-8 point-of-care mouthrinse test, after which a full-mouth clinical examination was performed to assess their periodontal and oral health. The aMMP-8 levels in mouthrinse were significantly lower among healthy patients compared with patients in more severe periodontitis stages and grades (Kruskal–Wallis test and Dunn–Bonferroni test for pairwise post-hoc comparisons; p < 0.01 and p < 0.05, respectively). Furthermore, aMMP-8 levels were less correlated with plaque levels than bleeding on probing (BOP) (Spearman’s rho = 0.269, p < 0.001; Spearman’s rho = 0.586, p < 0.001); respectively). Thus, aMMP-8 was more robust to the confounding effects of oral hygiene than traditional periodontal parameter bleeding on probing. The aMMP-8 point-of-care mouthrinse test can be utilized as an adjunctive and preventive diagnostic tool to identify periodontal disease, classified by stage and grade, and ongoing periodontal breakdown chairside in clinical practice in only 5 min. Overall, integrating aMMP-8 into the new periodontitis classification system seems beneficial.

17 March 2006 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
CXChristiana Xajigeorgiou
Christiana Xajigeorgiou
DSDimitra Sakellari
Dimitra Sakellari
TSTheodora Slini
Theodora Slini
ABAnneta Baka
Anneta Baka
AKAntonis Konstantinidis
Antonis Konstantinidis

28 October 2010 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
MMM Mataftsi
M Mataftsi
LSL Skoura
L Skoura
DSD Sakellari
D Sakellari

9 May 2005 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
DSD. Sakellari
D. Sakellari
KAK. N. Arapostathis
K. N. Arapostathis
AKA. Konstantinidis
A. Konstantinidis

1 January 2003 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
DSDimitra Sakellari
Dimitra Sakellari
SKStavros Koukoudetsos
Stavros Koukoudetsos
MAMinas Arsenakis
Minas Arsenakis
AKAntonis Konstantinidis
Antonis Konstantinidis

25 October 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
IRIsmo T. Räisänen
Ismo T. Räisänen
NANur Rahman Ahmad Seno Aji
Nur Rahman Ahmad Seno Aji
DSDimitra Sakellari
Dimitra Sakellari
AGAndreas Grigoriadis
Andreas Grigoriadis
IRIina Rantala
Iina Rantala
TSTimo Sorsa
Timo Sorsa
Active matrix metalloproteinase-8 (aMMP-8) is a promising biomarker candidate for the modern periodontal and peri-implant disease diagnostics utilizing the chairside/point-of-care oral fluid technologies. These rapid biomarker analysis technologies utilize gingival crevicular fluid (GCF), peri-implant sulcular fluid (PISF), or mouth rinse as the oral fluid matrices that can be collected patient-friendly and non-invasively without causing bacteremia. aMMP-8, but not total or latent proMMP-8, has been shown to be a relevant biomarker to be implemented to the latest 2017 classification system of periodontitis and peri-implantitis. Thus, aMMP-8 point-of-care-testing (POCT)—but not total or latent proMMP-8—can be conveniently used as an adjunctive and preventive diagnostic tool to identify and screen the developing and ongoing periodontal and peri-implant breakdown and disease as well as predict its episodic progression. Similarly, aMMP-8 POCT provides an important tool to monitor the treatment effect of these diseases, but also other diseases such as head and neck cancer, where it can identify and predict the rapid tissue destructive oral side-effects during and after the radiotherapy. Additionally, recent studies support aMMP-8 POCT benefitting the identification of periodontitis and diabetes as the escalating risk diseases for COVID-19 infection. Overall, aMMP-8 POCT has launched a new clinical field in oral medicine and dentistry, i.e., oral clinical chemistry.